Fiche société
Anne Lindblad
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications2liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| propranolol LAThe purpose of this study is to compare the reduction in the number of severe headache days at six months in people with chronic migraine treated with topiramate and propranolol versus those treated with topiramate and a placebo. | Migraine | Phase 3 | À vérifier | United States | À vérifier |
| propranolol LAThe purpose of this study is to compare the reduction in the number of severe headache days at six months in people with chronic migraine treated with topiramate and propranolol versus those treated with topiramate and a placebo. | Migraine | Phase 3 | À vérifier | United States | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| propranolol LA | Migraine | Phase 3 | NCT00772031 | CMTT — NINDS CRC Chronic Migraine Treatment Trial | COMPLETED |
Publications
2| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| propranolol LA | Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: a placebo controlled study. | Cephalalgia : an international journal of headache | ||
| propranolol LA | Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine. | Neurology |